Literature DB >> 5283025

Treatment of meningeal leukemia with pyrimethamine.

G F Geils, C W Scott, C M Baugh.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5283025

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  7 in total

1.  Methodichlorophen as anti-tumor drug.

Authors:  L A Price; J H Goldie; B T Hill
Journal:  Br Med J       Date:  1975-04-05

2.  Letter: Pyrimethamine poisoning.

Authors:  J Armata
Journal:  Br Med J       Date:  1973-12-29

3.  Salivary elimination of pyrimethamine.

Authors:  R A Ahmad; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1981-01       Impact factor: 4.335

4.  Initial clinical experience with a simultaneous combination of 2,4-diamino-5(3',4'-dichlorophenyl)-6-methylpyrimidine (DDMP) with folinic acid.

Authors:  P Alberto; R Peytremann; R Medenica; M Beretta-Piccoli
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

5.  Phase I clinical trial and pharmacology of 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (metoprine) (DDMP) and folinic acid (CF).

Authors:  R de Jager; D Dupont; J J Rodzynek; C Dorlet; G Lagrange
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

Review 6.  Current recommendations and future prospects in the treatment of toxoplasmosis.

Authors:  R E McCabe; S Oster
Journal:  Drugs       Date:  1989-12       Impact factor: 9.546

7.  Studies concerned with overcoming resistance to methotrexate: a comparison of the effects of methotrexate and 2,4-diamino-5-(3',4'-dichlorophenyl)-6-methylpyrimidine (BW50197) on the colony forming ability of L5178Y cells.

Authors:  B T Hill; J H Goldie; L A Price
Journal:  Br J Cancer       Date:  1973-09       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.